In-vitro Diagnostics Companies

  • Report ID: 1354
  • Published Date: Jun 13, 2025
  • Report Format: PDF, PPT

Key In-vitro Diagnostics Market Players:

    • Abbott Laboratories
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis
    • Roche Diagnostics
    • DiaSorin S. p. A.
    • Johnson & Johnson corporation
    • Becton, Dickinson and Company
    • Siemens Healthineers
    • Danaher Corporations
    • Bio-Rad Laboratories
    • Thermo Fisher Scientific 
    • Pfizer Inc.

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of in-vitro diagnostics is evaluated at USD 108.06 billion.

In-vitro Diagnostics Market size was valued at USD 102.16 billion in 2024 and is set to exceed USD 197.24 billion by 2034, expanding at over 6.8% CAGR during the forecast period i.e., between 2025-2034.

North America is likely to hold largest industry share by 2034.

The key market players include Abbott Laboratories, Roche Diagnostics, DiaSorin S. p. A., Johnson & Johnson corporation, Becton, Dickinson and Company, Siemens Healthineers, Danaher Corporations, Bio-Rad Laboratories, Thermo Fisher Scientific, Pfizer Inc.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos